Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
287
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
+17M
-
Total reported value, excl. options
-
$3.82B
-
Value change
-
+$675M
-
Put/Call ratio
-
0.79
-
Number of buys
-
169
-
Number of sells
-
-130
-
Price
-
$35.80
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2023
366 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q2 2023.
Guardant Health, Inc. - Common Stock (GH) has 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 124M outstanding shares and own 86.05% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.8M shares), BlackRock Inc. (9.68M shares), FMR LLC (8.8M shares), ALLIANCEBERNSTEIN L.P. (4.46M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.22M shares), EVENTIDE ASSET MANAGEMENT, LLC (4.01M shares), Temasek Holdings (Private) Ltd (3.96M shares), Capital International Investors (2.9M shares), Point72 Asset Management, L.P. (2.71M shares), and MILLENNIUM MANAGEMENT LLC (2.43M shares).
This table shows the top 287 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.